Abstract Submission

Abstract Submission Template

* Category of Submission

Presenting Author:

The Presenting Author will receive all correspondence from NASP and must be one of the co-authors listed on the submitted abstract. By submitting an abstract to the conference, the presenting author assumes responsibility for the following:

  • Ensuring that all authors have read the abstract and agreed to be co-authors.
  • Notifying all co-authors of any changes to the conference, as may be communicated by NASP and sharing all correspondence with all co-authors.
  • Disclosure of any prior presentation.
  • Agreeing that at least one author will attend the NASP meeting to present the poster.

* Financial Disclosure

NO Financial Relationships to Disclose

Financial Relationships to Disclose

* Abstract

Abstracts cannot exceed 2,500 characters (body of the abstract, including spaces). Abstracts should be structured in such a way as to include the following 5 sections:

Total Character Count: 0

Total Character Count: 0

* So we can correct any technical glitches that may occur during upload related to special characters, please upload either a Word or PDF version of your abstract. Please note: This is for reference purposes only if needed. The reviewers will only be provided with what has been submitted via the abstract submission portal fields.


* Required Fields

By submitting this abstract for consideration, you:

  • Attest that all co-authors are included and approve the submission
  • Agree that the presenting author will attend the meeting
  • Confirm that the submission is accurate and complete
  • Will, if you indicated yes to the publication authorization above, complete and sign the NASP Author Agreement authorizing NASP to publish the abstract, if accepted, in the Journal of Drug Assessment.